Skip to main content

ACR 2019 - Report from Day 3 (Tuesday)

Here's my summary of key studies presented Tuesday. 

Tofacitinib in Polyarticular JIA

Can The Happiest Subspecialists Experience Burnout?

The Medscape’s Physician Lifestyle & Happiness Report 2019 crowned rheumatologists as the happiest subspecialists. We topped the list with 65% of the respondents indicating that they were happy outside of work.

Rheum for Interpretation: Three Tips to Apply RCTs to Your Clinical Practice

At the 2019 ACR Annual Meeting in Atlanta, almost 500 presentations discussed new randomized controlled trials (RCTs). We are lucky to have so much research activity in our field, but applying an RCT to your daily practice can be challenging.

Muscle Loss and Frailty in Rheumatic Disease

“If exercise could be purchased in a pill, it would be the single most widely prescribed and beneficial medicine in the nation.” —Robert H. Butler, MD, first director of the National Institute on Aging.

IL-17 inhibitors in non-radiographic axial SpA

This meeting sees new data on using anti-IL-17 agents in non-radiographic axial SpA. Up until now these patients have only had TNF inhibitors available, so data about the efficacy of IL17 inhibitors is really important.

Tweets

Kanika Monga, MD DrKanikaMonga

8 months ago

Abstract #0626 Are there really differences between non-radiographic and radiographic axial spondyloarthritis? Data from the Spanish Atlas #ACR19 @RheumNow https://t.co/hg3U2QjpFp

Mike Putman EBRheum

8 months ago

A short piece I wrote for @RheumNow on classification criteria and their role in diagnosis / clinical practice 1. These are meant for research! 2. We use them for diagnosis anyway... 3. Remember their limitations when doing so! @RheumNow https://t.co/SSr28zkc0U https://t.co/EDzgWPIxXe

Philip Robinson philipcrobinson

8 months ago

Video from @gensler_MD on AS and nr-axSpA studies presented at #ACR19 @rheumnow https://t.co/fcn9zCxouU via @YouTube

Mike Putman EBRheum

8 months ago
#ACR19 Abst#2728 Plenary: Upadacitinib RCT in AnkSpa Improved ASAS40 at wk14 (52% v 26% PLBO, NNT~4) and SPARCC MRI Scores. Good safety profile but too small a trial to assess properly Overall an encouraging result, JAKi impacting yet another disease! @RheumNow https://t.co/GtB9wHuoNp

Maeve Gamble MaeveGamble

8 months ago

Gout tip: If you have a “failed” MTP aspirate, blow out end of needle onto a slide and examine it. #ACR19 @RheumNow #gout

Dr. Rachel Tate uptoTate

8 months ago

What’s your first line therapy for AS? Write below if you use something else! @RheumNow #ACR19

Dr. Antoni Chan synovialjoints

8 months ago

The C-VIEW open-label study found a significant reduction in the AAU flare rate in axSpA pts with a history of recurrent AAU during the first 48 wks of Certolizumab. Pts also experienced significant improvement in axSpA disease activity #ACR19 @RheumNow

Dr. Antoni Chan synovialjoints

8 months ago

Over two years, there can be progression of facet joint ankylosis with most progression occurring in the thoracic spine. Whole spine low dose CT is a research tool to study progression of facet joint in radiographic axSpA patients. van Gaalen #ACR19 @rheumnow

Dr. Antoni Chan synovialjoints

8 months ago

The discrepancy in diagnosis between rheumatologists and radiologists reflects the increasing insecurity of including only BME of SIJ as the major criterium for diagnosing axSpA. Structural changes are also important. Baraliakos #ACR19 @RheumNow #axialspondyloarthritis

Dr. Antoni Chan synovialjoints

8 months ago

Semi-axial combined with standard semi-coronal scans in MRI protocols for sacroiliitis improved recognition of non-specific BME, which is in the posterior lower ilium in association with SIJ features, and in the anterior upper sacrum #ACR19 @RheumNow #axialspondyloarthritis

×